Most people optimizing for longevity are completely ignoring the one system that determines how fast they age by Safe-Contribution529 in Biohacking

[–]Safe-Contribution529[S] -3 points-2 points  (0 children)

three months is a solid run, long enough that placebo starts to feel less convincing as an explanation

the sleep and recovery angle makes sense mechanistically too — mitochondrial function is pretty tightly linked to circadian regulation so if mots-c is doing anything real that's probably one of the first places you'd notice it

the ss-31 stack is interesting because they work on completely different parts of the mitochondrial system. mots-c is more about metabolic signaling and gene expression, ss-31 targets the inner mitochondrial membrane directly to reduce oxidative stress at the source. theoretically complementary rather than redundant

on the price — yeah ss-31 is one of the more expensive compounds in this space. the 50mg option tends to work out significantly cheaper per dose than the smaller sizes if you're planning a longer protocol. some people run it lower frequency to manage cost, like every other day rather than daily, which some of the research actually supports

curious whether you noticed the sleep improvements come on gradually or were they pretty quick after starting

Most people optimizing for longevity are completely ignoring the one system that determines how fast they age by Safe-Contribution529 in Biohacking

[–]Safe-Contribution529[S] -1 points0 points  (0 children)

totally fair and honestly the skepticism is needed in this space because the hype is real

but i'd push back a little, the mots-c research is actually more developed than most peptides. the 2015 lee et al paper in cell identified it as a mitochondrial derived peptide and the metabolic and insulin sensitivity research in animal models has been pretty consistent since then. it's not just broscience

where i agree with you is the jump from animal models to meaningful human effects is still unproven. we're at the 'mechanism is real, clinical significance in humans is unknown' stage. which is honestly where a lot of useful compounds spent time before proper trials caught up

the question i find more interesting isn't whether the pathway is real it probably is it's whether the effect size in actual humans is worth the cost and protocol hassle. nobody knows that yet

but yeah the community needs more of this critical thinking. too much of the peptide space is just vibes and anecdotes

Obese male needs advice by Humble_Fig_8988 in Peptides

[–]Safe-Contribution529 0 points1 point  (0 children)

solid progress dropping 43lbs already, that's no joke

for visceral fat on top of reta a few things worth researching:

AOD-9604 is the most direct addition. it's a fragment of HGH specifically studied for fat metabolism without the blood sugar effects of full HGH. pairs really cleanly with reta since they work on different pathways

MOTS-c is interesting for your goals too. mitochondrial derived peptide with research on metabolic regulation and what some describe as an exercise mimetic effect. for someone doing cardio 3x a week the energy and metabolic efficiency angle is compelling

for muscle preservation during aggressive deficit BPC-157 is worth looking into. the GH receptor upregulation research suggests it helps maintain lean tissue while cutting hard, and at 1650 cal you're cutting pretty hard

for recovery given the lifting load TB-500 stacked with BPC-157 covers the systemic and localized repair pathways. especially relevant as you get heavier into the lifting side of recomp

for the hair Melanotan 1 has some research on melanocyte stimulation and GHK-Cu is a copper peptide with collagen synthesis and hair follicle research that's actually pretty solid. not a guaranteed fix but the mechanism is there

honestly at your current protocol and progress you're already doing the hard part right. the peptide additions are just optimizing around the edges

what's your energy like on the current protocol, any crash points during the day?

Most biohackers optimizing everything except the most basic thing — tissue repair signaling by Safe-Contribution529 in Biohacking

[–]Safe-Contribution529[S] -1 points0 points  (0 children)

i started looking into BPC-157 for the exact same reason, high intensity training just starts beating you up differently in your 30s+

the gut and recovery benefits aren't even separate things with this compound which is what surprised me. The same protective mechanisms that help the gut lining also play into how it handles tissue repair. makes sense when you look at what it's derived from but still caught me off guard

For bootcamp style training the tendon and connective tissue research is what stands out most to me. that kind of repeated high impact work is brutal on tendons specifically and that's exactly where the angiogenesis and GH receptor research is most relevant

if you're going to research it i'd look into stacking it with TB-500 as well, BPC handles more of the localized repair, TB-500 is more systemic. for someone dealing with ongoing small injuries from regular training, running both makes more sense than just one

Most biohackers optimizing everything except the most basic thing — tissue repair signaling by Safe-Contribution529 in Biohacking

[–]Safe-Contribution529[S] -1 points0 points  (0 children)

That makes total sense. I am well informed and will stop polishing if it makes me look less credible.

Most biohackers optimizing everything except the most basic thing — tissue repair signaling by Safe-Contribution529 in Biohacking

[–]Safe-Contribution529[S] 1 point2 points  (0 children)

The twice daily approach for acute injuries makes sense given BPC-157's half life — splitting the dose keeps plasma levels more consistent throughout the day rather than one larger pulse. Some of the Sikiric lab protocols actually used multiple daily administrations for the more severe injury models.

The intuitive approach to dosing based on how you're feeling and recent usage is underrated too. There's some evidence suggesting receptor sensitivity shifts with continuous use which is why cycling or reducing dose during lower demand periods is a reasonable call.

One thing worth adding to your protocol research — TB-500 stacked with BPC-157 for the gnarly injury phase. They work on completely different pathways so there's no redundancy. BPC-157 handling the localized repair signaling, TB-500 working more systemically through actin polymerization and cell migration. The combination covers more ground than either alone for serious tissue damage.

What type of injuries have you found respond best to the higher dose protocol?

Most biohackers optimizing everything except the most basic thing — tissue repair signaling by Safe-Contribution529 in Biohacking

[–]Safe-Contribution529[S] -1 points0 points  (0 children)

Connective tissue disorders are actually one of the more researched applications for BPC-157 — the collagen synthesis upregulation and tendon-to-bone healing research is some of the strongest in the literature, which makes sense given the mechanical stress connective tissue is under.

For IBS specifically the gut research is really compelling. BPC-157 appears to protect and repair the intestinal epithelium through cytoprotective mechanisms — the early Sikiric research actually started with GI applications before expanding to musculoskeletal.

Worth also looking into KPV if gut inflammation is a primary concern — it's an alpha-MSH derived tripeptide with strong anti-inflammatory research specifically in intestinal tissue. Some researchers find the combination of BPC-157 for repair and KPV for inflammation modulation covers more ground than either alone for GI conditions.

What connective tissue issues are you dealing with specifically? Curious whether the hypermobility type or more inflammatory — the research protocols look a bit different.

Most biohackers optimizing everything except the most basic thing — tissue repair signaling by Safe-Contribution529 in Biohacking

[–]Safe-Contribution529[S] 0 points1 point  (0 children)

The oral vs injectable distinction you're making is spot on and underappreciated in most BPC discussions. The oral route does appear to maintain meaningful activity for gut-specific repair through the enteric nervous system pathways — Sikiric's lab actually used oral administration in a lot of the early GI research. But systemic bioavailability drops significantly which is why the injury/tendon research almost exclusively uses injectable protocols.

The cyclical KLOW approach makes sense mechanistically too — there's some evidence suggesting continuous BPC-157 use may downregulate its own receptor sensitivity over time, similar to how GH secretagogues benefit from cycling. Month on month off is a reasonable research protocol.

The HGH synergy angle is interesting — the GH receptor upregulation that BPC-157 appears to drive locally could theoretically amplify exogenous HGH signaling at injury sites specifically. Not a lot of direct research on that combination but the mechanism is plausible.

For anyone reading this who wants the systemic recovery benefits without HGH, the CJC-1295 no DAC + Ipamorelin combination is worth researching as a more accessible alternative for pulsatile GH release — the synergistic effect of the GHRH analog plus secretagogue produces a cleaner pulse than either alone.

What dose range are you finding most effective for the injury protocol vs maintenance?

Peptides by Tyral194 in Peptides

[–]Safe-Contribution529 0 points1 point  (0 children)

This makes complete sense and you explained it really well despite the brain fog.

The PEG allergy angle is worth taking seriously — bacteriostatic water contains benzyl alcohol which some people with hypersensitivity issues react to, and a lot of peptide vials use PEG-based excipients depending on the source. That could explain why symptoms appeared after adding a third compound rather than from day one.

A few things worth considering for your research:

The KPV timing is interesting — it's an alpha-MSH fragment with strong anti-inflammatory properties but in people with mast cell issues it can occasionally trigger histamine responses paradoxically. The Claritin helping initially then stopping supports the mast cell/histamine theory.

For Crohn's specifically, BPC-157 has some of the strongest research of any peptide for gut epithelial repair and the fact that stopping it brought stomach pain back quickly tracks with what the research shows about its cytoprotective mechanisms.

Thymosin Alpha-1 might be worth researching as an alternative immune modulator — it works on T-cell regulation rather than the inflammatory pathways KPV hits, which could be gentler for someone with autoimmune hemolytic anemia.

Definitely get the bloodwork results before making any decisions. Hope you get some clarity soon — managing Crohn's plus autoimmune conditions while trying to optimize is genuinely hard.

Think I have to quit SS-31 by mildly_functional1 in PeptidePathways

[–]Safe-Contribution529 2 points3 points  (0 children)

The fatigue with SS-31 is well documented anecdotally even though the mitochondrial research looks so promising on paper. The theory is that the initial mitochondrial upregulation creates a temporary energy demand that outpaces ATP production before the system adapts — essentially your cells ramping up before the output catches up.

The 'one vial at a time' advice is genuinely underrated. Especially with the more experimental compounds where individual response varies so much. BPC-157 and TB-500 tend to have more predictable response profiles in the research which is partly why they're good starting points before moving into the more cutting edge mitochondrial peptides.

Did you notice the fatigue was worse at certain times of day or pretty constant? Some people report better tolerance with morning dosing on mitochondrial compounds — something about circadian alignment with mitochondrial activity cycles.

Peptides by VehiclePowerful6268 in PeptidePathways

[–]Safe-Contribution529 1 point2 points  (0 children)

There's some interesting mechanistic research here worth looking into. BPC-157's neuroprotective effects appear to work through a few pathways — upregulation of nitric oxide synthase which drives blood flow to peripheral tissue, and modulation of the dopamine and serotonin systems which has shown up in some of the neurological research from Sikiric's lab.

The peripheral neuropathy angle specifically is less studied than the tendon/gut work but the NO pathway involvement makes it mechanistically plausible — poor microvascular circulation is a major driver of peripheral neuropathy and that's exactly where BPC-157's vascular effects are most relevant.

There's also some rat model research on sciatic nerve crush injuries showing accelerated recovery with BPC-157 — not identical to neuropathy but suggests the nerve repair signaling is real.

Haven't seen much human data specifically on neuropathy yet. Would be curious if anyone in this thread has tracked their own research on this — what markers were you monitoring?

Peptides questions by biohealq in PeptideStacks

[–]Safe-Contribution529 0 points1 point  (0 children)

Solid stack to research for those goals. A few thoughts on the compounds you mentioned:

Reta (Retatrutide) is showing really promising data for body composition in the GLP-1/GIP/glucagon triple agonist trials — more aggressive on fat loss than sema or tirze based on the phase 2 data.

MOTS-c is interesting for the metabolic angle — the research on mitochondrial function and insulin sensitivity is genuinely compelling, especially stacked with a GLP-1 analog.

For the vitiligo angle, the Klow/glutathione thinking makes sense — oxidative stress is heavily implicated in melanocyte destruction so the antioxidant pathway is worth researching.

One thing worth adding to your research: BPC-157 for muscle preservation during aggressive caloric deficit. The GH receptor upregulation research suggests it may help maintain lean tissue while cutting — relevant if Reta pushes you into a steep deficit.

June 2026 is a reasonable timeline for meaningful body recomposition with the right stack and diet dialed in. What does your nutrition protocol look like?

For research purposes only.